JW (Cayman) Therapeutics Co. Ltd
JWCTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $489,083 | $780,425 | $1,425,278 | $5,053,099 |
| - Cash | $757,375 | $1,005,909 | $1,383,336 | $1,834,399 |
| + Debt | $422,404 | $318,795 | $279,128 | $147,035 |
| Enterprise Value | $154,112 | $93,311 | $321,070 | $3,365,735 |
| Revenue | $158,218 | $173,856 | $145,702 | $30,797 |
| % Growth | -9% | 19.3% | 373.1% | – |
| Gross Profit | $77,316 | $88,219 | $58,756 | $9,045 |
| % Margin | 48.9% | 50.7% | 40.3% | 29.4% |
| EBITDA | -$488,741 | -$655,747 | -$752,274 | -$738,703 |
| % Margin | -308.9% | -377.2% | -516.3% | -2,398.6% |
| Net Income | -$590,624 | -$767,996 | -$846,135 | -$702,328 |
| % Margin | -373.3% | -441.7% | -580.7% | -2,280.5% |
| EPS Diluted | -1.43 | -1.87 | -2.06 | -1.76 |
| % Growth | 23.5% | 9.2% | -17% | – |
| Operating Cash Flow | -$333,443 | -$398,418 | -$536,722 | -$561,198 |
| Capital Expenditures | -$15,425 | -$14,580 | -$76,874 | -$73,087 |
| Free Cash Flow | -$348,868 | -$412,998 | -$613,596 | -$634,285 |